Comparison of prognostic models in advanced hepatocellular carcinoma patients undergoing Sorafenib: A multicenter study.
Dig Liver Dis
; 53(8): 1011-1019, 2021 Aug.
Article
in En
| MEDLINE
| ID: mdl-33353858
Full text:
1
Database:
MEDLINE
Therapeutic Methods and Therapies TCIM:
Terapias_biologicas
/
Aromoterapia
Main subject:
Severity of Illness Index
/
Carcinoma, Hepatocellular
/
Sorafenib
/
Liver Neoplasms
/
Antineoplastic Agents
Type of study:
Etiology_studies
/
Evaluation_studies
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Country/Region as subject:
Europa
Language:
En
Journal:
Dig Liver Dis
Year:
2021
Type:
Article